Roche Holding said a late-stage clinical trial that studied the effectiveness of a combination of drugs to treat lung cancer didn't reach its primary goal.

Quarterly net interest income was a weaker-than-expected 3.11 billion ringgit, down from 3.17 billion ringgit a year ago, while its noninterest income jumped 21% to 2.34 billion ringgit. Net ...